𝔖 Bobbio Scriptorium

✦ LIBER ✦

Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years

✍ Scribed by Moroni, G.; Quaglini, S.; Gallelli, B.; Banfi, G.; Messa, P.; Ponticelli, C.

Book ID: 121821050
Publisher: SAGE Publications
Year: 2013
Tongue: English
Weight: 290 KB
Volume: 22
Category: Article
ISSN: 0961-2033
DOI: 10.1177/0961203313492576

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surgery of lumbar and thoracolumbar scol

Surgery of lumbar and thoracolumbar scolioses in adults over 50. Morbidity and survival in a multicenter retrospective cohort of 180 patients with a mean follow-up of 4.5years

✍ Blamoutier, A.; Guigui, P.; Charosky, S.; Roussouly, P.; Chopin, D. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 479 KB

Survival and symptom progression in a ge

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years

✍ Martin Prince; Amanda Chetwynd; Wendy Newman; Jane V. Metcalf; Oliver F.W. James 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Progression of glycaemia and cardiovascu

Progression of glycaemia and cardiovascular risk factors in patients of different age groups with new type 2 diabetes over 5 years of follow-up in a diabetes quality improvement initiative

✍ Kirsten J. Coppell; Janet (EunHwa) Lee; Sheila M. Williams; Jim I. Mann 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 245 KB

2136 Does concurrent chemotherapy improv

2136 Does concurrent chemotherapy improve local control and survival over radiotherapy alone or induction chemotherapy in stage III non-small cell lung cancer (NSCLC)? Results at 3 years in 140 patients (PTS) with a minimum follow-up of 24 months

✍ F. Reboul; Y. Brewer; P. Vincent; B. Chauvet; C.Félix Faure; M. Taulelle 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB